Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

The combination treatment showed a higher response rate but no significant survival benefits.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Ixekizumab has known and some unexpected side effects.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

The adapalene-benzoyl peroxide gel works better and faster for acne treatment than using either ingredient alone, with manageable side effects.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Platelet-rich plasma (PRP) can significantly improve melasma, a skin pigmentation disorder, but may not add benefits when used with certain other treatments.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Ixekizumab effectively treats generalized pustular psoriasis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Nilotinib can cause keratosis pilaris, a skin condition.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Combining certain treatments, including FOL005, may improve healing of difficult wounds.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

The PIRL laser cuts tissue with less damage and scarring than traditional methods.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.